What we doOur groundbreaking software predicts protein complex changes in response to diseases and drug treatments using a wide range of information on cellular processes. Revolutionize your drug discovery pipeline, optimize treatments, and personalize patient care through our innovative software tools.
Our groundbreaking software predicts protein complex changes in response to diseases and drug treatments using a wide range of information on cellular processes. Revolutionize your drug discovery pipeline, optimize treatments, and personalize patient care through our innovative software tools.
What We do
Cytocast is a data-driven biotechnology company, providing a cell simulation platform, that can revolutionize how we treat patients starting from drug discovery and development (Cytocast Digital Twin Cell™) to selecting the best treatment option for patients (Cytocast Digital Twin Patient™).
We offer cutting-edge technology solutions designed to enhance and support the healthcare industry's capabilities and bring meaningful progress to the field. It benefits a broad range of clients in the healthcare industry, including pharmaceutical companies, biotech firms, medical research organisations, and healthcare providers.
Our focus is evaluating drug efficacy and side effects in silico. Potential further applications of our technology include identifying and characterizing drug targets, finding drug repurposing potentials, optimizing drug development pipelines, identifying potential drug combinations and synergies, predicting patient responses to treatments, personalizing treatment plans for patients.
Contact us
Contact us today to learn more about how Cytocast's technology can benefit your organization and accelerate drug discovery, development, and progress toward new treatments and improved patient outcomes.
Contact us